Abstract

Background/aim This study aimed to investigate the relationship between the iodine concentration (IC) of perigastric fat tissue as assessed by dual-energy computed tomography (DECT) and serosal invasion of gastric cancer.Materials and methods A total of 41 patients underwent preoperative staging evaluation for gastric cancer using DECT between July 2015 and March 2018. Patients were divided into 2 groups based on pathology results: serosal invasion (stage T4a) and intact serosa (stages T1–T3). Cutoff values, the diagnostic efficacy of IC in the perigastric fat tissue, and the perigastric fat tissue/tumor (P/T) ratio were determined.Results Among the 41 patients, 22 had stage T4a gastric cancer and 19 patients had gastric cancer with a stage lower than T4a. The mean IC of perigastric fat tissue and the P/T ratio were significantly higher in patients with serosal invasion than in those with intact serosa (P < 0.001). During the arterial phase, the area under the curve (AUC) was 0.915 and 0.854 for the IC of perigastric fat tissue and the P/T ratio, respectively. During the venous phase, the AUC was 0.890 and 0.876 for the IC of perigastric fat tissue and the P/T ratio, respectively.Conclusion The IC in the perigastric fat tissue seems to be a reliable indicator for serosal invasion of gastric cancer.

Highlights

  • Gastric cancer remains one of the most important causes of cancer-related deaths worldwide [1,2,3]

  • The mean iodine concentration (IC) of perigastric fat tissue and the perigastric fat tissue/tumor (P/T) ratio were significantly higher in patients with serosal invasion than in those with intact serosa (P < 0.001)

  • The IC in the perigastric fat tissue seems to be a reliable indicator for serosal invasion of gastric cancer

Read more

Summary

Introduction

Gastric cancer remains one of the most important causes of cancer-related deaths worldwide [1,2,3]. Correct diagnosis and precise preoperative staging of gastric cancer are very important because these patients can be treated with laparoscopic or minimally invasive surgery [4]. The TNM staging system is usually used to stage gastric cancer, and T4 is described as a tumor that has spread through all the muscle layers outside the stomach and invades the serosa or adjacent structures [3]. Selection of the appropriate treatment options, including neoadjuvant chemotherapy or multiorgan surgery, depends on correct differentiation between stage T4 gastric cancer and T3 or earlier stages [5,6,7]. Computed tomography (CT) is the most common method used to identify the stages of gastric cancer and assess the local extension of the tumor, nodal disease, and

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call